NEXELL THE FASTEST GROWTH IN BIOTECHS NEXL Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NEXELL THE FASTEST GROWTH IN BIOTECHS NEXL

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Anthony G. Breuer who wrote (11)	10/10/1999 9:32:00 PM
From: LLCF	Read Replies (1) of 17

I'm thinking that the problem with NEXL is that they have a great product, only one approved, but their 'enabling technology' is a bridge to only a very small island at the moment.... if stem cells start to become widely used, it seems the upside here is substantial. I think it may behoove us to try and pay attention to where the future demand will come from, and then observe those trials or events which would validate their use. My thinking is that there may be some key uses/trials coming down the pipe, and understanding that could help us to 'pile in' as they come on line... ie. right before the revenue explosion and Wall St. taking notice. Thoughts????? Message 11494203 DAK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next